Sign up to save your podcasts
Or
Share Spotlight: How The FTC Could Hurt The Future Of Cancer Research
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Spotlight: How The FTC Could Hurt The Future Of Cancer Research
The Federal Trade Commission is taking action to block a biotech merger that will ultimately hinder the fight against cancer. Is it time to abolish this destructive agency? Steve Forbes on how this government body is doing more harm than good and on why the White House and Congress should act now.
Steve Forbes shares his What’s Ahead Spotlights each Tuesday, Thursday and Friday.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
View all episodes
By Forbes
4.8
492492 ratings
The Federal Trade Commission is taking action to block a biotech merger that will ultimately hinder the fight against cancer. Is it time to abolish this destructive agency? Steve Forbes on how this government body is doing more harm than good and on why the White House and Congress should act now.
Steve Forbes shares his What’s Ahead Spotlights each Tuesday, Thursday and Friday.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
More shows like Steve Forbes: What's Ahead
View all
WSJ Tech News Briefing
1,650 Listeners
WSJ What’s News
4,361 Listeners
WSJ Your Money Briefing
1,753 Listeners
Motley Fool Money
3,195 Listeners
WSJ Opinion: Potomac Watch
2,815 Listeners
Rule Breaker Investing
937 Listeners
The Ben Shapiro Show
153,960 Listeners
Grant’s Current Yield Podcast
665 Listeners
What the Hell Is Going On
617 Listeners
Elon Musk Podcast
267 Listeners
Barron's Streetwise
1,546 Listeners
Barron's Live
195 Listeners
Larry Kudlow Show
459 Listeners
Forbes Daily Briefing
12 Listeners
Forbes Newsroom
3 Listeners
Forbes Talks
4 Listeners
Kudlow
128 Listeners
Charles Payne's Unstoppable Prosperity Podcast
138 Listeners